Prazosin
Back to searchMolecule Structure
Scientific Name
Prazosin
Description of the Drug
Prazosin is an alpha-blocker that causes a decrease in total peripheral resistance and is used to treat hypertension.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00457
http://www.drugbank.ca/drugs/DB00457
Brand Name(s)
Not Available
Company Owner(s)
Dava Pharmaceuticals Inc, American Therapeutics Inc, Idt Australia Ltd, Watson Laboratories Inc, Pfizer Laboratories Div Pfizer Inc, Ani Pharmaceuticals Inc, Granules Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Teva Pharmaceuticals Usa, Purepac Pharmaceutical Co
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Adrenergic receptor alpha-1 | PROTEIN FAMILY | ANTAGONIST | CHEMBL2094251 |
Clinical Trial(s)
Unichem Links
| Atlas | prazosin | ||||
| SureChEMBL | SCHEMBL26524 | ||||
| PharmGKB | PA451093 | ||||
| Human Metabolome Database | HMDB0014600 | ||||
| DrugBank | DB00457 | ||||
| PubChem: Thomson Pharma | 14804776 | ||||
| PubChem | 4893 | ||||
| Mcule | MCULE-8104643269 | ||||
| LINCS | LSM-3079 | ||||
| Nikkaji | J10.000E | ||||
| PDBe | XRA | ||||
| BindingDB | 29568 | ||||
| EPA CompTox Dashboard | DTXSID4049082 | ||||
| DrugCentral | 4209 | ||||
| Brenda | 145979 | 167772 | 229811 | 145065 | 229810 |
| Guide to Pharmacology | 5385 | 503 | |||
| rxnorm | PRAZOSIN HYDROCHLORIDE | PRAZOSIN | MINIPRESS | ||
| KEGG Ligand | C07368 | ||||
| ChEBI | 8364 | ||||
| ZINC | ZINC000095616601 |
